BEAM stock · PG stock

BEAM vs PG

Beam Therapeutics Inc (BEAM) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.

Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.

Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.

Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.

Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.

BEAM currently screens at market cap $2.01B. PG currently screens at market cap $373.53B and trailing P/E 25.3.

Not investment advice. Open the BEAM and PG stock pages for the full models.

Not investment advice.

Popular Stock Comparisons